openPR Logo
Press release

Global Asthma Treatment Drugs Market Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast - 2022 to 2028

03-30-2022 01:01 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Orion Market Reports

The global asthma treatment drugs market is expected to grow at a significant CAGR of 4.5% during the forecast period (2022-2028). The rising frequency of disorders including asthma, the aging population, increased research and development activities, and the existence of important market competitors are all contributing to this market growth. Asthma is a chronic respiratory condition in which mucus production, inflammation, and muscle tension restrict the airways of the lungs. Asthma is one of the most frequent diseases afflicting the world's population, as well as a life-threatening disorder that affects a patient's normal breathing. It is a chronic disorder that causes dyspnea, bronchospasm, and reversible blockage of airflow by stretching and narrowing the lungs' air passageways.

A full report of Global Asthma Treatment Drugs Market is available at:https://orionmarketreports.com/global-asthma-treatment-drugs-market/94535/  

Asthma affects more adult women than adult men in the US. According to the Centers for Disease Control and Prevention's 2020 report, almost 25 million Americans suffer from asthma. This equates to almost one in every thirteen Americans, including 8% of adults and 7% of children. Asthma affects around 20 million persons in the US. Furthermore, there has been a significant increase in the number of smokers, which leads to asthma symptoms. In the US alone, around 36.5 million adults currently smoke cigarettes, and more than 16 million are living with a smoking-related illness. Smoking damages almost every organ in the body and increases the risk for coronary heart disease, stroke, lung cancer, and several other types of cancer.

The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers and acquisitions, geographical expansion, new product launches, and product innovation to remain competitive in the marketplace. For instance, the US Food and Medicine Administration (FDA) approved AstraZeneca's asthma drug Fasenra, a pre-filled, single-use auto-injector, for self-administration in October 2019. GlaxoSmithKline Plc and Iqvia Pty Ltd launched a phase III clinical trial in March 2021 to assess the efficacy and safety of GSK3511294 (Depemokimab) in adults and adolescents patients with severe uncontrolled asthma. In October 2023, the study is projected to be completed. Similarly, in February 2021, AstraZeneca Plc, in partnership with Amgen Inc, began a phase I clinical trial in children aged 5 to 11 years with asthma to examine the pharmacokinetic (PK) characteristics of a single subcutaneous (SC) dosage of tezepelumab. In September 2021, the experiment was completed.

Market Coverage

The market number available for - 2022-2028
Base year- 2021
Forecast period- 2022-2028
Segment Covered- 
By Drug Class
Regions covered-
North America
Europe
Asia-Pacific
Rest of the World
Competitive Landscape: GlaxoSmithKline Plc, Merck & Co Inc., and AstraZeneca Plc, among others.

Key questions addressed by the report

What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How has COVID-19 impacted the market?
Deviation from the pre-COVID-19 forecast
Most affected region and segment
Who is the leader in the market?
How are players addressing challenges to sustain growth?
Where is the investment opportunity?

Global Asthma Treatment Drugs Market Report by Segment

By Drug Class

Bronchodilators
Anti-Inflammatory Drugs
Monoclonal Antibodies
Combination Drugs

 

Media Contact:

Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404

About Us:

Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Asthma Treatment Drugs Market Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast - 2022 to 2028 here

News-ID: 2590987 • Views: 130

More Releases from Orion Market Reports

Global Airlift Bioreactor Market Competitive Landscape, Growth Factors, Revenue …
The global airlift bioreactor market is expected to grow at a significant CAGR of 10.5% during the forecast period(2022-2028).The growth of the market is mainly driven by the rise in the biopharmaceutical industry and the increasing prevalence of various chronic diseases such as cancer, diabetes, heart diseases, and viral illnesses. According to the Reserve Bank of India (RBI), the Indian Pharmaceutical sector contributed nearly 2% to India's GDP. Moreover, the
Global Automotive Selective Catalytic Reduction (SCR) Market Competitive Landsca …
The global automotive selective catalytic reduction (SCR) market is expected to grow at a CAGR of 8.5% during the forecast period (2022-2028). In the past few years, vehicle norms tightened around fuel-consuming vehicles such as gasoline, and diesel. Such norms caused the innovation of SCR units for diluting the NOx emission. To reduce emissions, existing vehicles can be fitted with devices, normally referred to as retrofitting. Diesel particulate filters can
Tennis Wear Market Research Report 2022-2028 | Share, Global Trends, Key Players …
The global tennis wear market is anticipated to grow at a CAGR of 2.8% during the forecast period (2022-2028). Furthermore, an increase in fitness consciousness among consumers and a rapid rise in per capita disposable income are expected to drive demand for tennis wear market. Moreover, the trend of sports apparel among young sports enthusiasts, as well as advancements in the formulation of tennis wear, drive market growth. However, a
Beauty Tools Market By Size, Demand Analysis, Type, Statistics, Regions and Fore …
The beauty tools market is anticipated to grow at a significant CAGR of 10.3% during the forecast period (2022-2028). The rise in the use of online/e-commerce platforms, the advent of beauty and cosmetic tutorials, and the high influence of social media and brand endorsements are all driving the expansion of the beauty tools market. Furthermore, the increased popularity of on-demand beauty services has boosted sales of different beauty devices/tools such

All 5 Releases


More Releases for Asthma

Asthma-Pipeline Review H2 2017
ReportsWeb.com published “Asthma” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Asthma-Pipeline Review, H2 2017, provides an overview of the Asthma (Respiratory) pipeline landscape. Asthma is a chronic disease involving the airways in the lungs. These airways, or bronchial tubes, allow
Landmark Asthma Study Demonstrates Device Choice Determines Asthma Control
Monaghan Medical Corporation understands that for those with asthma, particularly children, choosing the device that best delivers their medication is an important consideration. Plattsburgh, NY, USA -- Monaghan Medical Corporation understands that for those with asthma, particularly children, choosing the device that best delivers their medication is an important consideration. Research has shown that even when using the same metered-dose inhaler (MDI), not all valved holding chambers perform equally well.[1] A landmark
Asthma-Pipeline Review H2 2017
ReportsWeb.com published “Asthma” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Asthma-Pipeline Review, H2 2017, provides an overview of the Asthma (Respiratory) pipeline landscape. Asthma is a chronic disease involving the airways in the lungs. These airways, or bronchial tubes, allow
Asthma Therapeutics Market- Global Industry Analysis 2025
Asthma is a chronic disease of airways of the lungs and characterized by various symptoms such as bronchospasm, and pulmonary airway obstructions. The symptoms of asthma include coughing, chest tightness, wheezing, and breath shortness. Asthma is considered to be caused by a combination of environmental factors and genetic factors. The few environmental factors include exposure to allergens and air pollution. The symptoms can be prevented by avoiding exposure to allergens
Asthma Therapeutics Market Size - Industry Share Report
Asthma is a chronic disease of airways of the lungs and characterized by various symptoms such as bronchospasm, and pulmonary airway obstructions. The symptoms of asthma include coughing, chest tightness, wheezing, and breath shortness. Asthma is considered to be caused by a combination of environmental factors and genetic factors. The few environmental factors include exposure to allergens and air pollution. The symptoms can be prevented by avoiding exposure to allergens
Allergic asthma bronchiale: Plasmapheresis with Clinical Success
"Therapeutic Apheresis or adsorption methods would seem advisable in patients with severe therapy-resistant allergic asthma bronchiale, particularly in status asthmaticus when medical therapy is inadequate. One could also consider Therapeutic Apheresis in the chronic steroid dependent asthmatic to decrease steroid requirements when indicated," Dr. Rolf Bambauer and colleagues suggest in their textbook "Therapeutic Plasma Exchange and Selective Plasma Separation Methods". Based on the assumption that plasmapheresis can interrupt the allergic